Skip to content

Effect evaluation of different modes of antioxidant therapy on reproductive endocrine in patients with PCOS

Effect evaluation of different modes of antioxidant therapy on reproductive endocrine in patients with PCOS

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036431
Enrollment
Unknown
Registered
2020-08-23
Start date
2020-11-09
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

control group:none
study group1:antioxidant therapy on every subject
study group 2:antioxidant therapy only on subjects with high risk factors

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-40 years old; 2. having pregnancy plan.

Exclusion criteria

Exclusion criteria: 1. Presence of hyperprolactinemia,thyroid dysfunction,adrenal disease,diabetes and other endocrine abnormalities; 2. chronic diseases of important organs; 3. adenomyosis or hysteromyoma (with uterine volume greater than 2 months of pregnancy or single intramural myoma larger than 5 cm); 4. tuberculosis,adhesions or other mucosa lesion; 5. having taken vitamin A, C, D, E or other antioxidant preparations in recent 3 months; 6. having contraindication of contraceptive use; 7. history of allergy to intervention drugs; 8. having diseases not suitable for pregnancy; 9. difficulty in following-up.

Design outcomes

Primary

MeasureTime frame
Androgen level;oxidative stress level;level of VIT C;level of VIT E;ER score;diameter of follicle before ovulation;level of IR;cycles of ovulation;

Secondary

MeasureTime frame
LH/FSH ratio;level of E2 on ovulation;thickness of endometrium before ovulation;conception;BMI;

Countries

China

Contacts

Public ContactZhewei WANG

Shanghai First Maternity and Infant Hospital

wangzhewei99@163.com+86 18616615605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026